about
Amniotic Fluid Stem Cells: A Novel Source for Modeling of Human Genetic DiseasesApplications of Induced Pluripotent Stem Cells in Studying the Neurodegenerative DiseasesReprogramming cells with synthetic proteinsPhysiological maturation and drug responses of human induced pluripotent stem cell-derived cortical neuronal networks in long-term cultureChallenges and opportunities toward enabling phenotypic screening of complex and 3D cell models.Multiparametric Phenotypic Screening System for Profiling Bioactive Compounds Using Human Fetal Hippocampal Neural Stem/Progenitor Cells.The Endogenous Hallucinogen and Trace Amine N,N-Dimethyltryptamine (DMT) Displays Potent Protective Effects against Hypoxia via Sigma-1 Receptor Activation in Human Primary iPSC-Derived Cortical Neurons and Microglia-Like Immune CellsHuman pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.Early-stage development of human induced pluripotent stem cell-derived neurons.Chapter 17 Sterile Plate-Based Vitrification of Adherent Human Pluripotent Stem Cells and Their Derivatives Using the TWIST Method.Human Pluripotent Stem Cell-Derived Retinal Ganglion Cells: Applications for the Study and Treatment of Optic Neuropathies.Distinct Neurodegenerative Changes in an Induced Pluripotent Stem Cell Model of Frontotemporal Dementia Linked to Mutant TAU ProteinA reproducible and versatile system for the dynamic expansion of human pluripotent stem cells in suspension.High-throughput screen for compounds that modulate neurite growth of human induced pluripotent stem cell derived neurons.Protein Kinase-A Inhibition Is Sufficient to Support Human Neural Stem Cells Self-Renewal.Amniotic fluid stem cell models: A tool for filling the gaps in knowledge for human genetic diseases
P2860
Q26750573-3E4340C4-3055-4C0A-8834-E46D06F3DA5AQ26799331-F0FFDC62-EA1C-4011-A5D6-CD1A97E34447Q26853155-B96D3DAA-EE01-4D80-A193-56D8339B6962Q27314513-B71B4E7F-9A10-48B9-847A-0CEDDDD8C397Q35602409-C3B772F8-51F3-416A-92A2-47667AE8B1E4Q35738255-B3F776AE-2CB8-481D-B5F3-4CD7A22BF3C9Q37253512-3E262B9F-7BF5-47B0-B9C3-74DEBCBB96A1Q38428477-450CB3D5-42EE-40AE-873D-E579C076F6FFQ41311531-80F49302-D352-4C79-8724-0D091315085EQ41597167-F830342B-ED34-446D-8F66-4E440718BE1EQ42099855-5DB0DBFA-C934-4B6A-A20E-C2C3F4658621Q42723993-EC05D5C3-E529-457E-B44A-3B87172B9B95Q48109644-59FC5117-34C1-4246-91BE-D0D0D18EEBA2Q48183777-C6AE3163-70D0-400F-89C6-668C59C20718Q53369649-85D3F092-9E3D-453D-9B16-F0B4BC31982BQ57153004-EA6AE23C-37C5-4498-9C87-905E453FD62C
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
iPS cell derived neuronal cells for drug discovery.
@en
type
label
iPS cell derived neuronal cells for drug discovery.
@en
prefLabel
iPS cell derived neuronal cells for drug discovery.
@en
P2093
P1476
iPS cell derived neuronal cells for drug discovery.
@en
P2093
Peter Reinhardt
Ralf Heilker
Stefanie Traub
P304
P356
10.1016/J.TIPS.2014.07.003
P577
2014-08-03T00:00:00Z